• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Maspin在胰腺肿瘤中的表达:Maspin免疫组织化学在鉴别诊断中的应用。

Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis.

作者信息

Oh Young Lyun, Song Sang-Yong, Ahn Geunghwan

机构信息

Department of Diagnostic Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Appl Immunohistochem Mol Morphol. 2002 Mar;10(1):62-6. doi: 10.1097/00129039-200203000-00011.

DOI:10.1097/00129039-200203000-00011
PMID:11893038
Abstract

Maspin is a unique member of the serpin family, which inhibits tumor invasion and metastasis of the human breast and prostate cancers. Immunohistochemical evaluation of the maspin expression in pancreatic neoplasms has never been performed. The authors examined the expression of maspin in various pancreatic neoplasms to investigate its usefulness as an adjunct diagnostic marker. Formalin-fixed, paraffin-embedded tissue sections from 107 pancreatic neoplasms were immunostained with anti-maspin antibody using an EnVision+ System. Maspin was expressed in all ductal adenocarcinomas, of which 78.9% (30/38) were high expressors and 21.1% (8/38) were low expressors. All 13 intraductal papillary mucinous tumors and 11 of the 13 mucinous cystic tumors reacted to maspin with stronger expressions in carcinomatous lesions. In contrast, acinar cell carcinoma, pancreatic endocrine tumors, solid-pseudopapillary tumors, and serous cystadenomas demonstrated no maspin expression. In addition, nonneoplastic pancreatic parenchyma and chronic pancreatitis lacked expression. The current study suggests that maspin may be of importance in the pathobiology of pancreatic neoplasms with epithelial origin, especially pancreatic tumors that are composed of mucin-producing cells. It may be useful in separating ductal adenocarcinoma from acinar cell carcinoma, pancreatic endocrine tumor, solid-pseudopapillary tumor, and chronic pancreatitis, especially in needle biopsy specimens.

摘要

Maspin是丝氨酸蛋白酶抑制剂(serpin)家族的一个独特成员,它可抑制人类乳腺癌和前列腺癌的肿瘤侵袭和转移。从未有人对胰腺肿瘤中maspin表达进行过免疫组织化学评估。作者检测了maspin在各种胰腺肿瘤中的表达,以研究其作为辅助诊断标志物的效用。使用EnVision+系统,用抗maspin抗体对107例胰腺肿瘤的福尔马林固定、石蜡包埋组织切片进行免疫染色。Maspin在所有导管腺癌中均有表达,其中78.9%(30/38)为高表达,21.1%(8/38)为低表达。所有13例导管内乳头状黏液性肿瘤和13例黏液性囊性肿瘤中的11例对maspin有反应,癌性病变中表达更强。相比之下,腺泡细胞癌、胰腺内分泌肿瘤、实性假乳头状肿瘤和浆液性囊腺瘤未显示maspin表达。此外,非肿瘤性胰腺实质和慢性胰腺炎也无表达。当前研究表明,maspin可能在上皮起源的胰腺肿瘤的病理生物学中具有重要意义,尤其是由产生黏液的细胞组成的胰腺肿瘤。它可能有助于将导管腺癌与腺泡细胞癌、胰腺内分泌肿瘤、实性假乳头状肿瘤和慢性胰腺炎区分开来,尤其是在针吸活检标本中。

相似文献

1
Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis.Maspin在胰腺肿瘤中的表达:Maspin免疫组织化学在鉴别诊断中的应用。
Appl Immunohistochem Mol Morphol. 2002 Mar;10(1):62-6. doi: 10.1097/00129039-200203000-00011.
2
Prognostic significance of maspin in pancreatic ductal adenocarcinoma.乳腺丝抑蛋白在胰腺导管腺癌中的预后意义
Korean J Intern Med. 2004 Mar;19(1):15-8. doi: 10.3904/kjim.2004.19.1.15.
3
Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray based study.Maspin在胰腺腺癌与慢性胰腺炎的鉴别诊断中具有重要作用:一项基于组织芯片的研究。
Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):59-63. doi: 10.1097/01.pai.0000203037.25791.21.
4
Expression of the tumor suppressor gene Maspin in human pancreatic cancers.肿瘤抑制基因Maspin在人类胰腺癌中的表达。
Clin Cancer Res. 2001 Apr;7(4):812-7.
5
Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas.抑癌基因maspin在胰腺导管内乳头状黏液性肿瘤中的表达及其意义
Hepatobiliary Pancreat Dis Int. 2008 Feb;7(1):86-90.
6
Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.Maspin在胰腺导管腺癌中的预后意义:223例手术切除病例的组织芯片分析
Mod Pathol. 2007 May;20(5):570-8. doi: 10.1038/modpathol.3800772. Epub 2007 Mar 30.
7
Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas.Maspin在胰腺导管腺癌中的表达的临床病理意义及分子调控
Cancer Lett. 2003 Sep 25;199(2):193-200. doi: 10.1016/s0304-3835(03)00390-2.
8
Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.胰腺导管腺癌最佳免疫组织化学组合(pVHL、Maspin、S100P、IMP-3)的重新评估和鉴定。
Arch Pathol Lab Med. 2012 Jun;136(6):601-9. doi: 10.5858/arpa.2011-0326-OA.
9
Expression and regulation of tumor suppressor gene maspin in breast cancer.抑癌基因maspin在乳腺癌中的表达及调控
Clin Breast Cancer. 2002 Oct;3(4):281-7. doi: 10.3816/CBC.2002.n.032.
10
Expression and subcellular localization of maspin in human ovarian epithelial neoplasms: correlation with clinicopathologic features.人卵巢上皮性肿瘤中maspin的表达及亚细胞定位:与临床病理特征的相关性
J Egypt Natl Canc Inst. 2005 Sep;17(3):173-83.

引用本文的文献

1
The paradoxical role of SERPINB5 in gastrointestinal cancers: oncogene or tumor suppressor?丝氨酸蛋白酶抑制剂B5(SERPINB5)在胃肠道癌症中的矛盾作用:癌基因还是肿瘤抑制因子?
Mol Biol Rep. 2025 Feb 3;52(1):188. doi: 10.1007/s11033-025-10293-w.
2
Usefulness of Adding Maspin Staining to p53 Staining for EUS-FNA Specimens of Pancreatic Ductal Adenocarcinoma.在胰腺导管腺癌的超声内镜引导下细针穿刺活检(EUS-FNA)标本中,将maspin染色添加到p53染色中的效用。
J Clin Med. 2022 Oct 16;11(20):6097. doi: 10.3390/jcm11206097.
3
SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma.
SLC5A8 核易位和表达缺失与胰腺导管腺癌不良预后相关。
Pancreas. 2012 Aug;41(6):904-9. doi: 10.1097/MPA.0b013e31823f429f.
4
Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma.Maspin肿瘤抑制基因在肺腺癌中的预后意义。
J Cancer Res Clin Oncol. 2004 Aug;130(8):475-9. doi: 10.1007/s00432-004-0571-x. Epub 2004 Jun 12.
5
Prognostic significance of maspin in pancreatic ductal adenocarcinoma.乳腺丝抑蛋白在胰腺导管腺癌中的预后意义
Korean J Intern Med. 2004 Mar;19(1):15-8. doi: 10.3904/kjim.2004.19.1.15.